# Whether Control of Serum Uric Acid (SUA) Improves Survival After Pancreatic Cancer

> **NCT07091526** · — · RECRUITING · sponsor: **Hepatopancreatobiliary Surgery Institute of Gansu Province** · enrollment: 168 (estimated)

## Conditions studied

- Serum Uric Acid

## Interventions

- **DIAGNOSTIC_TEST:** serum uric acid test

## Key facts

- **NCT ID:** NCT07091526
- **Lead sponsor:** Hepatopancreatobiliary Surgery Institute of Gansu Province
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-29
- **Primary completion:** 2026-12-29
- **Final completion:** 2026-12-29
- **Target enrollment:** 168 (ESTIMATED)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07091526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07091526, "Whether Control of Serum Uric Acid (SUA) Improves Survival After Pancreatic Cancer". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT07091526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*